+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Recent advances in melanoma treatment - American Society of Clinical Oncology (ASCO) 2012 perspective



Recent advances in melanoma treatment - American Society of Clinical Oncology (ASCO) 2012 perspective



Contemporary Oncology 16(3): 197-200



The 2012 ASCO (American Society of Clinical Oncology) annual meeting has been held once again at the McCormick Conference Center in Chicago, Illinois, where ASCO has booked a 10-year run for the meeting. The meeting was attended by more than 30,000 oncology professionals from around the world. Of more than 4500 abstracts published at the meeting, 310 were related to melanoma. Here we report the results of the most interesting clinical trials presented at the meeting. Apart from updated overall survival (OS) results of a phase 3 study evaluating the efficacy of vemurafenib and some new data on ipilimumab (expanded access program [EAP] and treatment of patients with brain metastases) we report on practice changing trials: a phase 3 (BREAK) trial evaluating efficacy of dabrafenib and a phase 3 study (METRIC) assessing trametinib in the treatment of metastatic melanoma patients. Another encouraging treatment strategy is combination of dabrafenib and trametinib evaluated in a phase I/II study. Results of new immune checkpoint targeting by monoclonal antibody anti-PD1 (BMS-936558) in an early phase trial in monotherapy or in combination with a multipeptide vaccine in metastatic melanoma patients are presented. Also, results of dendritic cell-based vaccine (randomized phase II trial) immunization in patients with high risk resected melanoma are shown. Furthermore, results of other melanoma immunotherapy strategies evaluated in early phase studies are reported.

(PDF emailed within 0-6 h: $19.90)

Accession: 055398110

Download citation: RISBibTeXText

PMID: 23788878

DOI: 10.5114/wo.2012.29283


Related references

Advances of treatment of small cell lung cancer in 2012 American Society of Clinical Oncology Annual Meeting. Zhongguo Fei Ai Za Zhi 15(11): 672-676, 2014

Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary. Journal of Oncology Practice 13(9): 621-625, 2017

ASCO-Update 2006 - Neuigkeiten vom 42. Meeting der American Society of Clinical Oncology/ASCO 2006. Zeitschrift fuer Gastroenterologie 44(10): 1065-1072, 2006

Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. Annals of Surgical Oncology 19(11): 3313-3324, 2013

Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. Journal of Clinical Oncology 30(23): 2912-2918, 2012

Impact of the new American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines on the determination of breast cancer HER2 status. 2008

2012 american society of clinical oncology and american society of hypertension: 27th annual scientific meeting and exposition. P & T 37(8): 471-477, 2012

Compte rendu du congrs de l'American Society of Clinical Oncology (ASCO). La Revue de Médecine Interne 14(8): 755-756, 1993

35th annual meeting of the ASCO. American Society of Clinical Oncology. Bulletin du Cancer 86(9): 779-781, 1999

ASCO debates high-dose chemotherapy. American Society of Clinical Oncology. Lancet 343(8911): 1493-1493, 1994

44(e) Congrès de l'ASCO (American Society of Clinical Oncology): Chicago, 30 mai-3 juin 2008. Journal de Chirurgie 145(5): 504-508, 2008

American society of clinical oncology asco 25th annual meeting may 21 23 1989. Anesthesiology (Hagerstown) 72(3): 587-588, 1990

American Society of Clinical Oncology (ASCO) 25th Annual Meeting May 2123, 1989. Anesthesiology 72(3): 587-588, 1990

Actualites sur la gemcitabine lors du congres de l'American Society of Clinical Oncology (ASCO, 2002). Bulletin du Cancer (Montrouge) 89(Numero Special): S134-S144, 2002

American Society of Clinical Oncology 2012 Annual Meeting: highlights from the gynecologic oncology track. International Journal of Gynecological Cancer 22(9): 1634-1639, 2013